New Di-Gesic controls

New conditions are to apply to the dispensing of dextropropoxyphene, including Di-Gesic and Doloxene, from 7 December.  The conditions have been imposed by the Administrative Appeals Tribunal, which allowed the drug to remain on the Australian Register of Therapeutic Goods (ARTG), but with conditions to ensure the safe use of these medicines.

The conditions require the manufacturer Aspen Pharmacare Australia to have arrangements in place designed to ensure that doctors and dentists complete and sign a new Prescriber Confirmation Form when prescribing Di-Gesic or Doloxene and pharmacists only dispense these medicines if the patient has provided a signed Prescriber Confirmation Form

More informattion for pharmacists and consumers can be found on the  TGA web site - www.tga.gov.au/safety/alerts-medicine-dextropropoxyphene-qa.htm

Source: www.guild.org.au/news-events/forefront/volume-3-number-46/new-di-gesic-controls, Tuesday 27 November 2013